(Q35122861)

6 August 2017

0 references

Factors influencing elimination and distribution of fleroxacin: metaanalysis of individual data from 10 pharmacokinetic studies (English)

1 reference

6 August 2017

1 reference

1 reference

Reigner BG

1

1 reference

6 August 2017

Welker HA

series ordinal

2

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 March 1996

1 reference

Antimicrobial Agents and Chemotherapy

6 August 2017

published in

1 reference

6 August 2017

volume

40

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

575-580

1 reference

Single-dose pharmacokinetics of oral fleroxacin in bacteremic patients

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163160

Should clearance be normalised to body surface or to lean body mass?

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163160

Alternative approaches to estimation of population pharmacokinetic parameters: comparison with the nonlinear mixed-effect model

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163160

Analysis of pharmacokinetic data using parametric models. III. Hypothesis tests and confidence intervals

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163160

Fleroxacin: in-vitro activity worldwide against 20,807 clinical isolates and comparison to ciprofloxacin and norfloxacin.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163160

Single and multiple dose pharmacokinetics of fleroxacin.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163160

Single- and multiple-dose pharmacokinetics of fleroxacin, a trifluorinated quinolone, in humans

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163160

Pharmacokinetics and tissue penetration of Ro 23-6240, a new trifluoroquinolone

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163160

In vitro activity of Ro 23-6240, a new difluoroquinolone derivative, compared with that of other antimicrobial agents

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163160

Penetration of fleroxacin into human and animal tissues

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163160

Effects of acute febrile infectious diseases on the oral pharmacokinetics and effects of nitrendipine enantiomers and of bisoprolol

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163160

Penetration of fleroxacin into human lung, muscle, and fat tissue

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163160

Prediction of creatinine clearance from serum creatinine

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163160

Estimation of population characteristics of pharmacokinetic parameters from routine clinical data

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163160

Disposition of fleroxacin, a new trifluoroquinolone, and its metabolites. Pharmacokinetics in renal failure and influence of haemodialysis

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163160

Comparative oral pharmacokinetics of fleroxacin and pefloxacin

27 September 2018

1 reference

12 December 2020

The penetration of fleroxacin into bronchial mucosa

1 reference

12 December 2020

Clinical pharmacokinetics and tolerance of fleroxacin in healthy male volunteers

1 reference

12 December 2020

Pharmacokinetics and body fluid penetration of fleroxacin in healthy volunteers

1 reference

12 December 2020

Metabolism of fleroxacin in man

1 reference

12 December 2020

Determination of the new fluoroquinolone fleroxacin and its N-demethyl and N-oxide metabolites in plasma and urine by high-performance liquid chromatography with fluorescence detection

1 reference

12 December 2020

Disposition of fleroxacin, a new trifluoroquinolone, and its metabolites. Pharmacokinetics in elderly patients

1 reference

12 December 2020

Aging, Total Body Potassium, Fat-free Mass, and Cell Mass in Males and Females Between Ages 18 and 85 Years

1 reference

12 December 2020

Identifiers

PMC publication ID

163160

1 reference

6 August 2017

1 reference